ReviewArthritis research & therapy2003
Behçet's disease.
Review in Arthritis research & therapy, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 114 citations in OpenAlex.
- Recommendations for the Management of Neuro-Behçet's Disease by the Japanese National Research Committee for Behçet's Disease.Internal medicine (Tokyo, Japan) · 2020Pooled it
- HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.Arthritis and rheumatism · 2009Pooled it
- Neuro-Behçet's disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis.Clinical and experimental immunology · 2025Review
- Validity and reliability of a checklist for patients with Behçet's disease based on the International Classification of Functioning, Disability and Health.Rheumatology international · 2022Article
- Characterization of autologous platelet rich plasma (PRP) and its biological effects in patients with Behçet's Disease.Regenerative therapy · 2021Article
- Treatment of Connective Tissue Disease-Related Intractable Disease with Biological Therapeutics.Open access rheumatology : research and reviews · 2021Review
- Thiol/disulfide homeostasis in patients with ocular-active and ocular-inactive Behçet disease.International ophthalmology · 2020Article
- Moesin expression is correlated with its involvement in patients with Behcet's disease.Archives of medical science : AMS · 2020Article
- GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet's disease.Arthritis research & therapy · 2018Article
- Cytokines Modulate the "Immune-Metabolism" Interactions during Behçet Disease: Effect on Arginine Metabolism.International journal of inflammation · 2015Article
- Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease.Journal of immunology research · 2015Review
- Interleukin 6 and cognitive dysfunction.Metabolic brain disease · 2014Review
- Syndromes of hearing loss associated with visual loss.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2014Review
- The role of CTLA-4 exon-1 49 A/G polymorphism and soluble CTLA-4 protein level in egyptian patients with Behçet's disease.BioMed research international · 2014Article
- Proinflammatory cytokines and C-reactive protein in uveitis associated with Behçet's disease.Mediators of inflammation · 2014Article
- New insights into HLA class I association to Behçet's syndrome in Iranian Azari patients.Auto- immunity highlights · 2013Article
- The Evaluation of Saliva Flow Rate, pH, Buffer Capacity, Microbiological Content and Indice of Decayed, Missing and Filled Teeth in Behçet's Patients.Balkan medical journal · 2013Article
- Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features.Orphanet journal of rare diseases · 2013Review
- Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.Modern rheumatology · 2012Article
- Clinical and Pathological Manifestations with Differential Diagnosis in Behçet's Disease.Pathology research international · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Behçet's disease is characterized by recurrent aphthous stomatitis, uveitis, genital ulcers, and skin lesions. The role of the HLA-B*51 gene has been confirmed in recent years, although its contribution to the overall genetic susceptibility to Behçet's disease was estimated to be only 19%. The production of a variety of cytokines by T cells activated with multiple antigens has been shown to play a pivotal role in the activation of neutrophils. As regards the treatment, anti-tumor necrosis factor alpha therapy has been shown to be effective for mucocutaneous symptoms as well as for sight-threatening panuveitis, although a randomized, controlled trial is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.